Adverse event causing death or study drug discontinuation · adults with renal vasculitis for maintenance therapy
Azathioprine showed no clear difference in adverse events causing death or study drug discontinuation compared with methotrexate (low certainty).
1 finding from 1 review
Severe adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine may leads to lower severe adverse events compared with methotrexate (low certainty).
1 finding from 1 review
Death at 6 months · adults with renal vasculitis for maintenance therapy
Antibiotics showed no clear difference in death at 6 months compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Relapse · adults with renal vasculitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Kidney function · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dialysis · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Remission · adults with renal vasculitis for maintenance therapy
Antibiotics showed no clear difference in remission at one year compared with placebo (low certainty).
1 finding from 1 review
Relapse · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Discontinuation of medication due to adverse events · adults with renal vasculitis for maintenance therapy
Antibiotics showed no clear difference in adverse events causing study drug discontinuation compared with placebo (low certainty).
1 finding from 1 review
Urinary tract infection · adults with renal vasculitis for maintenance therapy
Antibiotics may leads to lower infection (urinary tract infection) compared with placebo (low certainty).
1 finding from 1 review
Death · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Kidney function · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dialysis · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · adults with renal vasculitis for maintenance therapy
Leflunomide showed no clear difference in relapse compared with methotrexate (low certainty).
1 finding from 1 review
Intervention not reported
Total number of adverse events · adults with renal vasculitis
The intervention showed no clear difference in total number of adverse events (low certainty).
1 finding from 1 review
Serious adverse events* · adults with renal vasculitis for maintenance therapy
Leflunomide showed no clear difference in serious adverse events* compared with methotrexate (low certainty).
1 finding from 1 review
Infection · adults with renal vasculitis for maintenance therapy
Leflunomide showed no clear difference in infection compared with methotrexate (low certainty).
1 finding from 1 review
Intervention not reported
Serious infections · adults with renal vasculitis
The intervention may leads to higher serious infections (low certainty).
1 finding from 1 review
Death at final · adults with renal vasculitis
Pulse cyclophosphamide showed no clear difference in death at final compared with continuous cyclophosphamide (low certainty).
1 finding from 1 review
Serum creatinine (mg/dL) · adults with renal vasculitis
1 finding from 1 review